Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-21

Clinical Trial Update: Modified Atkins Diet Versus Levetiracetam for Refractory Childhood Epilepsy [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial comparing Modified Atkins Diet to Levetiracetam for refractory childhood epilepsy (Phase 2/Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)
  • Modified Atkins Diet

Snippet

Sponsor: Lady Hardinge Medical College | Conditions: Refractory Childhood Epilepsy | Phase 2, Phase 3 | Status: UNKNOWN